130 related articles for article (PubMed ID: 38406915)
21. [Clinicopathological and molecular genetic characteristics of childhood diffuse large B cell lymphoma].
Huang H; Yang WP; Xu HY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):209-11. PubMed ID: 22780976
[No Abstract] [Full Text] [Related]
22. [Burkitt's lymphoma--a case report].
Obeid L; Schär B; Heitzmann F; Bargetzi M
Praxis (Bern 1994); 1999 Sep; 88(36):1444-8. PubMed ID: 10500420
[TBL] [Abstract][Full Text] [Related]
23. Dose-adjusted EPOCH-R for Burkitt lymphoma.
Hoelzer D
Clin Adv Hematol Oncol; 2014 Nov; 12(11):777-9. PubMed ID: 25674718
[No Abstract] [Full Text] [Related]
24. Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis.
Linschoten M; Kamphuis JAM; van Rhenen A; Bosman LP; Cramer MJ; Doevendans PA; Teske AJ; Asselbergs FW
Lancet Haematol; 2020 Apr; 7(4):e295-e308. PubMed ID: 32135128
[TBL] [Abstract][Full Text] [Related]
25.
Sachpekidis C; Exadaktylou P; Katsampoukas D; Moralidis E; Arsos G
Hell J Nucl Med; 2020; 23(1):76-78. PubMed ID: 32222732
[TBL] [Abstract][Full Text] [Related]
26. [Primary cutaneous follicle centre lymphoma: report of a case].
Rong YF; He LM; Zhang YS; Feng YZ
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):769-70. PubMed ID: 24447559
[No Abstract] [Full Text] [Related]
27. [Successful treatment with dose-adjusted EPOCH-R for triple-hit lymphoma having BCL2, BCL6 and MYC translocations].
Hashimoto A; Fujimi A; Kanisawa Y; Nakajima C; Hayasaka N; Yamada S; Okuda T; Minami S; Matsumoto T; Shibata T; Hamaguchi K; Kamihara Y; Iwasaki S; Kato J
Rinsho Ketsueki; 2015 Jul; 56(7):905-10. PubMed ID: 26256929
[TBL] [Abstract][Full Text] [Related]
28. Unusual presentation of Ewing sarcoma in the adrenal gland: a secondary malignancy from a survivor of Burkitt lymphoma.
Lim SH; Lee JY; Lee JY; Kim JH; Choi KH; Hyun JY; Ko YH; Lee J; Kim SJ; Kim WS
Jpn J Clin Oncol; 2013 Jun; 43(6):676-80. PubMed ID: 23564674
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Green TM; Young KH; Visco C; Xu-Monette ZY; Orazi A; Go RS; Nielsen O; Gadeberg OV; Mourits-Andersen T; Frederiksen M; Pedersen LM; Møller MB
J Clin Oncol; 2012 Oct; 30(28):3460-7. PubMed ID: 22665537
[TBL] [Abstract][Full Text] [Related]
30. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children].
Yang WP; Zhu CD; Gong LP; Lü BB; Zou Y; Zhong HS; Xiao Q; Wu Y; Xu HY; Zeng ST; Huang H
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):759-64. PubMed ID: 20079016
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of chemotherapy in Chinese patients with AIDS-related Burkitt lymphoma and diffuse large B-cell lymphoma: An observational study.
Xiao J; Du S; Dai G; Gao G; Yang D; Zhao H
Sci Rep; 2017 May; 7(1):1905. PubMed ID: 28507339
[TBL] [Abstract][Full Text] [Related]
32. Primary non-Hodgkin,s lymphoma of the uterine cervix.
Hanprasertpong J; Hanprasertpong T; Thammavichit T; Kongkabpan D; Tungsinmunkong K; Chandeying N
Asian Pac J Cancer Prev; 2008; 9(2):363-6. PubMed ID: 18712992
[TBL] [Abstract][Full Text] [Related]
33. [Primary gastric lesion in Berkitt-like lymphoma].
Zvonkov EE; Boriakh EA; Magomedova AU; Kravchenko SK; Kremenetskaia AM; Obukhova TN; Kaplanskaia IB; Samoĭlova RS; Makhinia VA; Shavlokhov VS; Krasil'nikova BB; Egorova EK; Danishian KI
Ter Arkh; 2005; 77(7):85-8. PubMed ID: 16116918
[No Abstract] [Full Text] [Related]
34. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
[TBL] [Abstract][Full Text] [Related]
35. Is dose-adjusted EPOCH-R the new standard for high-risk Burkitt lymphoma?
Lim KJC; Filshie R
Lancet Haematol; 2023 Dec; 10(12):e942-e943. PubMed ID: 37922924
[No Abstract] [Full Text] [Related]
36. Rapidly growing periodontal enlargement.
Manganaro AM; Phillips KM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 May; 89(5):535-8. PubMed ID: 10807707
[No Abstract] [Full Text] [Related]
37. Dose-adjusted EPOCH-R: a feasible alternative for Burkitt lymphoma in resource-constrained settings.
Jindal N; Jain A; Lad D; Prakash G; Khadwal A; Malhotra P
Br J Haematol; 2020 Sep; 190(6):e362-e363. PubMed ID: 32614462
[No Abstract] [Full Text] [Related]
38. Primary Burkitt's lymphoma of the ovary.
Cyriac S; Srinivas L; Mahajan V; Sundersingh S; Sagar TG
Afr J Paediatr Surg; 2010; 7(2):120-1. PubMed ID: 20431226
[No Abstract] [Full Text] [Related]
39. A rare cause of gastric malignancy: Burkitt's lymphoma.
Doycheva I; Tanner S; Zhou D; Samadder NJ
Endoscopy; 2013; 45 Suppl 2 UCTN():E432-3. PubMed ID: 24338176
[No Abstract] [Full Text] [Related]
40. Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Johnson NA; Slack GW; Savage KJ; Connors JM; Ben-Neriah S; Rogic S; Scott DW; Tan KL; Steidl C; Sehn LH; Chan WC; Iqbal J; Meyer PN; Lenz G; Wright G; Rimsza LM; Valentino C; Brunhoeber P; Grogan TM; Braziel RM; Cook JR; Tubbs RR; Weisenburger DD; Campo E; Rosenwald A; Ott G; Delabie J; Holcroft C; Jaffe ES; Staudt LM; Gascoyne RD
J Clin Oncol; 2012 Oct; 30(28):3452-9. PubMed ID: 22851565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
